Harness Therapeutics wins grant to develop disease-modifying Parkinson’s drug

▤ Summary

Harness Therapeutics won a grant to support development of a disease-modifying Parkinson’s drug. The announcement points to continued progress in its therapeutic pipeline and external validation from a funding source. This is relevant to the life sciences and pharma sector because it reflects R&D activity rather than a software product event. The item does not describe a software launch, corporate transaction, or executive change.

▦ Linked Companies